Wednesday, September 20, 2017
 
 
Company News: Page (1) of 1 - 09/07/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Point-of-care Biosensors Will Grow to a $33 Billion Market by 2027 Forecasts IDTechEx Research
 
(September 07, 2017)

BOSTON, September 7, 2017 /PRNewswire/ --

The brand-new IDTechEx Research report, Biosensors for Point-of-Care Testing: Technologies, Applications, Forecasts 2017-2027, predicts that point-of-care (PoC) biosensors will become a $33 billion market by 2027, with molecular diagnostic devices the main driver for this growth. The report gives a complete analysis of the important trends in the field of medical biosensors, and lists the new technologies and devices which are likely to be highly disruptive to the in-vitro diagnostics market.

     (Logo: http://photos.prnewswire.com/prnh/20140310/673848 )


     (Photo: http://mma.prnewswire.com/media/553244/IDTechEx_Point_of_Care_Biosensors.jpg )

Biosensors are used to detect and quantify biological material associated with a disease state or health condition (biomarkers). Biosensors are therefore powerful tools for diagnosis and monitoring. As technological advances allow for such tests to be conducted faster and on smaller devices, these tests are moving out of specialised laboratories and closer to the patient at the point-of-care.

This report is the first to comprehensively look at all commercial applications for point-of-care biosensors. It gives a complete picture of the industry, including the types of biosensors, the key players on the market and the emerging technologies.

In this analysis of the market, 'point-of-care' is defined as being portable and able to gives results in under one hour. Commercial biosensors are split in four categories: Lateral flow assays; Electrochemical test strips; Integrated cartridges; and Molecular Diagnostics.

In addition, the report gives a 10-year market forecast segmented by application, including infectious disease self-monitoring, glucose testing, cancer, cardiometabolic, pregnancy & fertility and genetic testing.

All the forecasts in this report show the revenues from the consumables (disposable devices) thereby giving a realistic view of the market size.

Biosensors for Point-of-Care Testing: Technologies, Applications, Forecasts 2017-2027 will be useful to any company wishing to be in the value chain of biosensors (materials suppliers, reagent suppliers, microfluidics, contract manufacturers, foundries). Find out more at http://www.IDTechEx.com/biosensors.

The two authors of the report, Dr Laura Baers and Dr David Pugh, will be presenting their analysis on PoC biosensors at the upcoming Business and Technologies Insight Forums hosted by IDTechEx in Seoul (19-21 September) and Tokyo (27-29 September). These forums address both the business and technological landscapes - providing clarity and significant market data to allow you to understand the real opportunities.


Contact:
Charlotte Hibbert
Marketing & Research Co-ordinator
[email protected]
UK: +44-(0)1223-810286

SOURCE IDTechEx

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Disease, Pregnancy, Surgery, Pregnancy, Business,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines